We think this finding has a profound impact on PJI management: 1) for those who presented with CRP > 35.43 and CAR > 0.847 before PRABCSI, more attention should be paid to evaluate whether the infection was controlled after PRABCSI. This evidence concerns the gene CRP and juvenile polyposis syndrome.